Pharmacogenetics

Research Frontiers in Targeted Therapy in ALK-Rearranged Lung Adenocarcinoma

Pharmacogenomic analysis of ALK fusion variants and downstream signaling mutations predicting ALK inhibitor sensitivity and resistance mechanisms.

All Pharmacogenetics PhD categories